Bluebird Bio (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BLUE | AMGN | GILD | CELG | VRTX |
| Company | Bluebird Bio | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.9500 | 264.63 | 66.25 | 108.01 | 394.72 |
| High | 1.0300 | 269.38 | 66.83 | 108.59 | 396.98 |
| Low | 0.9400 | 260.68 | 66.16 | 107.27 | 391.25 |
| Last | 1.0200 | 268.93 | 66.76 | 108.24 | 394.28 |
| Change | +0.0670 | +6.18 | +0.60 | +0.11 | +0.80 |
| % Change | +7.03% | +2.35% | +0.91% | +0.10% | +0.20% |
| Volume | 8,178,400 | 3,380,300 | 10,657,000 | 191,230,496 | 1,342,100 |
| 20-Day Average Volume | 5,938,710 | 2,246,435 | 6,455,920 | 16,188,930 | 931,825 |
| Previous Close | 0.9530 | 262.75 | 66.16 | 108.13 | 393.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1746 | 272.56 | 69.90 | 108.17 | 405.52 |
| 20-Day Raw Stochastic | 18.87% | 29.59% | 10.79% | 63.25% | 10.74% |
| 20-Day Relative Strength | 41.06% | 43.95% | 31.30% | 64.69% | 37.76% |
| Weighted Alpha | -55.40 | +7.67 | -24.32 | +46.30 | +15.95 |
| Today's Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 56% Sell | 8% Sell | 72% Sell | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.27% since 04/12/24 | +0.62% since 04/12/24 | -1.92% since 04/12/24 | -1.97% since 11/13/19 | -0.57% since 04/12/24 |
| Low | 0.9200 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 391.01 on 04/18/24 |
| High | 1.1200 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 110.53 on 11/14/19 | 402.49 on 04/15/24 |
| 1-Month | |||||
| %Chg | -27.14% since 03/19/24 | -1.03% since 03/19/24 | -9.06% since 03/19/24 | +5.14% since 10/18/19 | -5.04% since 03/19/24 |
| Low | 0.9200 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 1.4900 on 03/21/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -19.37% since 01/19/24 | -12.63% since 01/19/24 | -23.52% since 01/19/24 | +13.63% since 08/20/19 | -9.37% since 01/19/24 |
| Low | 0.8790 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 1.9200 on 02/27/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -63.31% since 10/19/23 | -4.16% since 10/19/23 | -14.89% since 10/19/23 | +14.14% since 05/20/19 | +8.08% since 10/19/23 |
| Low | 0.8790 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 5.5300 on 12/08/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 104,197 | 140,812,720 | 82,374,304 | 77,035,920 | 101,698,464 |
| Shares Outstanding, K | 109,336 | 535,919 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 3,600,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -266,580,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 12,390,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -71,730,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 0.74 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.66 on 11/07/23 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 10.99 | 29.25 |